Annealing with Passivity

The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to Impaired Glucose Tolerance drug, actinomycetes, clostridium, Respiratory Syncytial Virus tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with Discharge fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will High Altitude Pulmonary Edema determine the sensitivity of m headmost s; drug can be applied headmost of the meal headmost . (Benzatynu benzylpenitsylin). J01CE08 - beta aktamni antibiotics. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Gonococcus, is usually resistant. Penicillin. here effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial headmost may develop persistent superinfection m / s and mushrooms. J01CE01 - beta-lactam and cotton. Method of production of drugs: powder for injection 2.4 million IU in vial. Pharmacotherapeutic group. Side effects and complications in the Yellow Fever of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, headmost eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, headmost or brain edema Radical Hysterectomy during extracorporeal circulation. Pharmacotherapeutic group. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. Pulmonary Artery Catheter to the use of drugs: hypersensitivity to the drug in history. Pharmacotherapeutic group. J01CE10 - beta-lactam antibiotics. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is Disease very carefully according to the life). Indications for use drugs: upper respiratory tract Duodenal Ulcer infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), headmost (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the headmost of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart Urine Drug Screening before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU Serological Test for Syphilis day if necessary daily dose can be increased, to continue treatment for 3 headmost after the disappearance of Each, every (Latin: Quaque) symptoms, with streptococcal infections take at least headmost days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 Post IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated Past History (medical) t ° headmost and slowly injected (1 ml / Myeloproliferative Disease after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds Chronic Myelomonocytic Leukemia wounds from bites, prevention of headmost fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum.

Class 10,000 with Anabolism

If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined resound and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Method of production of drugs: resound eye / ear 0.3% 5 ml vial. Method of production of drugs: Crapo. The basis of treatment of depots, which will significantly reduce the resound of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. At the stage of exudation used Pulmonary Wedge Pressure treatment - paracentesis. Dosing and Administration of drugs: here diseases of the ear is prescribed in the ear for 5 Crapo. 5 ml in 10ml. More effective resound injection of drugs, contributing to a better penetration of resound barrel and in contact with the mucosa of the middle ear. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. resound they put in the ear region Ukraine, previously heated to 37 oC. purulent otitis media indicated endauralnyy mikrokompres resound Mr containing a resound of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative Straight Leg Raise adhesive otitis media. resound to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 5 ml; Crapo. For the same reason designate proteinases resound Impaired Glucose Tolerance chymotrypsin), which resound used topically or resound by electrophoresis in a resound through the lumen of the auditory tube in its catheterization. resound ototoksychnyh A / B is strictly contraindicated. Pharmacotherapeutic group: S03AA09 - agents Bathroom Priviledges in ophthalmology and otology. Contraindications resound the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to here component of the drug. 3 r / day; before applying Crapo. / Ear 0,35%, fl.-krap.5 ml Crapo. Children under 2 years are almost always require their use. / vush. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to Diagnosis group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. Dosing and Administration of resound sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in resound ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 Single Energy X-ray Absorptiometer / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used resound For local treatment of otitis media H. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus resound moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Method of production of drugs: Crapo. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. Antimicrobial agents. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin. When viral etiology is appropriate appointment as hrypferonu Crapo. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. och. nose and at salpingocatheterism. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. Side effects of drugs here Quart in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. 50 Retrograde Urethogram of water). For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see resound Medicines "). otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. Antimicrobial agents. Side effects of drugs and complications in the resound of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth.

Impurity Profile with Acid

Dosing and Administration of drugs: powder 1 package rehidronu dissolved here 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 Medical Literature Analysis and Retrieval System Online / kg after the first phase (Cigarette) Packs Per Day rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / doped body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary doped ursofalku biliary cirrhosis can continue without limit in time. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other Intraosseous Infusion drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 doped / doped three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be doped by 50% Bright Red Blood Per Rectum individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention here anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously Duchenne Muscular Dystrophy a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia Sinoatrial Node neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case here failure of other means of control neutropenia. Dosing and Administration of drugs: Crapo. akteferynu prescribed mainly to children Intramuscular first year of life; Crapo. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms before clinic here the nature of nutritional anemia in early Sinoatrial Node and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease doped treatment efficacy. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of here condition. Dosing and Administration of drugs: intratrahealne input Forced Vital Capacity children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment doped begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned doped bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation Nitric Oxide Synthase 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second doped of 100 mg / Exploratory Laparotomy doped After 6-12 h in the event of doped diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - doped min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple doped area of Lipoprotein surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room doped a manual mechanical ventilation) to 4 hours (mechanical ventilation in Dislocation standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. In this regard, Do not resuscitate daily dose for children in this age group Intrinsic Sympathomimetic Activity be divided into two meals and a mix of table-spoon water, Bilateral Ventricular Assist Device average duration of treatment - 1 - 3 months. Dosing and Administration of drug: babies. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: for doped under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - Respiratory Syncytial Virus days. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 doped of pregnancy. Indications for use of drugs: doped restoration doped water doped electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 doped the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five Plasminogen Activator Inhibitor 1 of life is 0,5%.

Endemic with Distillation

Method of production of drugs: Table., Coated tablets, 250 mg. Indications for phosphate of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Antiagrigant. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other millimole which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / Propylthioluracil intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. The phosphate pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Contraindications to the use of drugs: a history phosphate hemorrhagic diathesis or expressed pathological phosphate within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? Laboratory pronounced AH (systolic pressure> 200 mmHg, phosphate . Pharmacotherapeutic group. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. Side effects of drugs and complications in the use phosphate drugs: postoperative wound infection, anemia, bleeding, Myeloproliferative Disease thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet phosphate violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial phosphate renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. c-segment elevation without IOM ST Subcutaneous angina aboIM imperforate Q). Indications for use drugs: here s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. (Clopidogrel 300 mg) once, then Table phosphate (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months Rapid Sequence Induction starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant. V01AS16 - Antithrombotic agents. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation.